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Abstract OBJECTIVE: There is increasing evidence for the contribution of obesity and its 
metabolic sequels in the development of arterial hypertension (AH). 
METHODS: The casual blood pressure (CBP), 24hABPM, ambulatory arterial 
stiffness index (AASI) and symmetric (sAASI) ambulatory arterial stiffness index 
(both derived from a 24 h ABPM) and selected laboratory tests were performed in 
130 obese (mean BMI SDS 4.2) adolescents at the mean age of 13.7 years. 
RESULTS: AH was diagnosed in 36.2%, and in 33.8% patients on the basis of CBP 
and 24hABPM respectively. There were significant correlations between: CBP-
SBP insulin level (fasting r=0.19, p=0.03 and post glucose load r=0.18, p=0.04), 
HOMA-IR (r=0.18, p=0.04), and uric acid (UA) level (r=0.35, p<0.001); CBP-
DBP and UA level (r=0.23, p=0.01). There were significant correlations between 
24hABPM parameters and cortisol secretion: dSBP and urinary free cortisol 
(r=0.3, p=0.03), nDBP and nMAP and cortisol rhythm (r=0.21, p=0.03). There 
a correlation between sAASI and creatinine level (r=0.29, p=0.002) and negative 
correlation between AASI and eGFR (r=–0.23, p=0.009). 
CONCLUSIONS: The increase of the CBP parameters is associated with insulin 
resistance and hyperuricemia, while the increase of ABPM results is proportional 
to the cortisol secretion in obese adolescents. 
INTRODUCTION
The prevalence of primary arterial hypertension 
(AH) has recently increased among pediatric pop-
ulation. While the reported prevalence in the late 
1970s was about 1%–2%, the rates reported in the 
early 2000s have increased up to 13–17% (Fixler et 
al. 1979; Sorof et al. 2002; Maldonado et al. 2011; 
Mazor-Aronovitch et al. 2014). The similar trend 
has been observed for obesity and its metabolic 
complications (Muntner et al. 2004). There is an 
increasing evidence for the association of these 
both disorders. The results of the NHANES study 
show that the increase of the BMI may cause an 
increase in systolic blood pressure (SBP) by 29% 
and diastolic blood pressure (DBP) by 12% (Munt-
ner et al. 2004). That may explain high prevalence 
of AH in overweight or obese pediatric patients, 
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reaching up to 30% in comparison to <5% in slim peers 
(Fixler et al. 1979; Sorof et al. 2002; Maldonado et al. 
2011; Mazor-Aronovitch et al. 2014).The development 
of the metabolic and hormonal complications in obese 
children is a long lasting process. The critical moment 
for the development of overt metabolic complications 
such as insulin resistance and subsequent type 2 diabe-
tes, lipid disorders and non alcoholic fatty liver disease 
and sub-clinical hormonal abnormalities is puberty. At 
that age many patients present already with AH. That 
suggest, that even sub-clinical metabolic abnormali-
ties may contribute to the development of the AH. The 
diagnosis of AH in children and adolescents is based 
on the average SBP and/or DBP that is measured on at 
least 3 occasions (casual blood pressure, CBP) and it’s 
comparison to the normal values for gender, age, and 
height. Since 2008 24-h ambulatory blood pressure 
monitoring (ABPM) has also been applied to children 
and adolescents (Urbina et al. 2008; Flynn et al. 2014). 
Also ABPM derived ambulatory arterial stiffness index 
(AASI) and symmetric AASI (s-AASI) are newly rec-
ognized cardiovascular risk factors (Dolan et al. 2006). 
The present study is a first attempt to compare CBP and 
ABPM results in obese adolescents, and to analyze their 
association with selected metabolic and hormonal com-
plications of the obesity.
MATERIAL AND METHODS
The study included 130 (71 girls, 59 boys) obese (mean 
BMI SDS 4.2, [Q1=3.2; Q3=5.5]) adolescents at the 
mean age of 13.7 [Q1=11.9; Q3=15.3] years. All par-
ticipants were at the pubertal age (Tanner stage III–V). 
Body weight and height were measured to the nearest 
0.1 kg and 0.1 cm, respectively, using a stadiometer 
(Harpenden, UK) and a balanced scale. As the standard 
of reference for calculating SDS for waist and hip cir-
cumference, normal values from the local population 
were used. Casual blood pressure measurement was 
done auscultatory, with a standard clinical sphygmoma-
nometer, with a cuff appropriate to the size of the child’s 
upper right arm. It was repeated three times, on three dif-
ferent ambulatory visits. SBP and DBP were calculated 
as the mean value of these three results (National High 
Blood Pressure Education Program Working Groupon 
High Blood Pressure in Children and Adolescents, 
2004). 24-hour BP monitoring was performed using an 
Ambulatory BP Monitor (Spacelabs 90217,USA), with 
a cuff which was the same size as the one used to mea-
sure casual blood pressure. It was set to take a reading 
every 15 minutes (day 6 a.m.–10:59 p.m.), and every 30 
minutes (night 11:00 p.m.–5:59 a.m.). The monitor-
ing was performed in a standard setting, patients went 
to sleep at 9–10 p.m. and got up at 6–7 a.m. Sleep and 
activity periods were established based on a diary com-
pleted by the child’s parents. Recordings with at least 
70% valid readings and at least one reading every hour 
were considered for the analysis. The following param-
eters were analyzed: mean 24-h systolic, diastolic, and 
mean arterial pressure (MAP), mean day-time systolic 
(dSBP), diastolic (dDBP), and MAP (dMAP), mean 
night-time systolic (nSBP), diastolic (nDBP), and MAP 
(nMAP). Blood pressure load was calculated separately 
for sleep and awake periods. BP load was defined as 
the percentage of valid ambulatory BP measurements 
above a set threshold value (95th percentile for sex and 
height) (Wühl et al. 2002). Loads in excess of 30% were 
considered elevated. Loads in excess of 50% were con-
sidered severely elevated. The calculation of nocturnal 
dipping was based on a formula by the American Heart 
Association: [(dSBP–nSBP)/dSBP] × 100. Normal dip-
ping was defined as a ≥10% decline in SBP (Urbina et 
al. 2008). White coat AH was defined as AH observed 
in CBP but not in ABPM. Masked AH was defined as a 
CBP within the normal range, but AH in ABPM. AASI 
was calculated according to the following formula: 1−
the regression slope of diastolic pressure on systolic 
BP, sAASI was calculated according to the following 
formula: 1−(correlation coefficient/regression slope 
of systolic on diastolic BP) (Wühl et al. 2002, Sorof & 
Potrman 2000). Uric acid (UA), triglycerides, total cho-
lesterol, LDL cholesterol, and HDL cholesterol concen-
trations were estimated in the fasting blood sample by 
the dry chemistry method with a Vitros 5.1.FF machine 
(Ortho-Clinical Diagnostics, Rochester, NY, USA). 
Urinary free cortisol was measured in the 24-h urine 
collection. Standard oral glucose tolerance tests were 
performed with the assessment of fasting and post-load 
glucose and insulin levels. HOMA-IR was calculated 
using the formula: [fasting insulin level (μIU/mL) × 
fasting glucose level (mmol/L)]/22.5. Blood cortisol 
levels were assessed twice: in the morning (8.00 a.m.) 
and evening (8.00 p.m.). 
Statistics
Categorical variables were expressed as counts and per-
centages. Empirical distribution of continuous variables 
was described using median, quartiles (notation used: 
Me [Q1;Q3]) and mean, standard deviation (notation 
used: mean (SD)). Statistical significance of differences 
between two independent groups was assessed using 
the Mann-Whitney test or chi-square test as appropri-
ate. Associations between continuous variables were 
examined by the Spearman’s rank correlation coef-
ficient. An association between a binary variable and 
a continuous variable adjusted for other variables was 
assessed by the use of a logistic regression model and 
reported using odds ratio (OR) with a 95% confidence 
interval (CI). A p-value less than 0.05 was considered 
an indication of a statistically significant result. All sta-
tistical analyses were performed using R 3.0 (R Devel-
opment Core Team, 2010). 
Ethics
The investigation was conducted according to the 
principles expressed in the Declaration of Helsinki. 
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The study has been approved by Jagiellonian Uni-
versity Bioethical Committee (decision number 
KBET/38/B/2008); all participants and their parents 
signed informed consent.
RESULTS 
Arterial hypertension, diagnosed on the basis of the 
mean value of SBP and DBP of three independent CBP 
measurements (>95th centile), was confirmed in 47 
(36.2%) of the study participants, 30 (42.3%) girls and 
17 (28.8%) boys. High normal BP (>90th centile) was 
recognized in 13 (10%) patients; 6 (8.4%) girls, 7 (11.9%) 
boys. Based upon CBP 28.4% of the subjects were clas-
sified as having systolic AH and 13.8 % were classified 
as having diastolic AH. On the basis of 24hABPM, AH 
was diagnosed in 44 patients (33.8%), 25 (35.2%) girls 
and 19 (32.2%) boys. White coat hypertension was 
recognized in 22 participants (9 boys, 13 girls; 46.8% 
of the patients with AH) and masked hypertension in 
21 (13 boys, 9 girls). Analysis of the 24hABPM results 
revealed significantly higher mean 24-hour values of 
BP parameters in patients with AH in CBP (24h SBP 
SDS: median value 1.07 [0.38;1.66] vs. 0.51 [–0.35;1.26], 
p<0.001, 24h DBP SDS: 0.22 [–0.40;0.82] vs. –0.28 
[–0.85;0.31], p=0.02, 24h MAP SDS: 0.62 [0.30;1.15] vs. 
0.26 [–0.55;0.82], p=0.01). Also median values of SBP 
and MAP during the activity period (06.00 am. –10.59 
pm.) were higher in AH patients (dSBP SDS: 0.76 
[0.10;1.54] vs. 0.16 [–0.53;0.96], p=0.01, dMAP SDS: 
0.28 [–0.15;1.15] vs. –0.07 [–0.72;0.57], p=0.01). Nev-
ertheless there were no significant differences between 
patients with and without AH concerning DBP during 
the activity period (dDBP SDS: –0.36 [–0.72;0.64] vs. 
–0.61 [–1.09;–0.02], p=0.05), BP parameters during the 
sleep period (11.00 p.m. – 05.59 a.m.) (nSBP SDS: 1.13 
[0.46;1.73] vs. 0.65 [0.04;1.46], p=0.06, nDBP SDS: 0.46 
[–0.17;1.22] vs. 0.39 [–0.18;1.07], p=0.73, nMAP SDS: 
1.00 [0.46;1.40] vs. 0.77 [0.15;1.36], p=0.14) and night 
dip percentage (10.9 [8.07;15.0] vs. 8.87 [6.39;12.6] , 
p=0.05) (Table 1). There were no significant differences 
concerning the percentage of elevated cases of MAP 
(>2.0 SD) in patients with and without AH – 6.38% 
vs. 4.82%, p=0.7. Patients with AH diagnosed on the 
basis of CBP presented with a significantly higher inci-
dence of elevated SBP load (42.6% vs. 22.9%, p=0.03). 
Surprisingly, there were no significant differences 
between patients with and without AH concerning a 
higher incidence of elevated DBP (21.3% vs. 10.8%, 
p=0.17) extremely elevated SBP load (17.0% vs. 9.6%, 
p=0.34), extremely elevated DBP load (2.13% vs. 1.2%, 
p=0.999) or abnormal night dip (42.6% vs. 60.2%, 
p=0.08). Patients with AH diagnosed on the basis of 
CBP presented at a higher median age (14.5 [12.5;16.2] 
vs. 13.0 [11.6;14.6] years, p=0.01) and BMI-SDS (5.20 
[3.33;6.22] vs. 3.87 [3.16;5.01], p=0.01). The analysis 
of girls and boys confirmed the difference concerning 
age in both groups, but BMI SDS was only higher in 
girls (a detailed comparison of the two groups is pre-
sented in Table 1). There was a significant correlation 
between SBP measured by CBP and fasting and 120’ 
post load insulin levels in OGTT (r=0.19, p=0.03 and 
r=0.18, p=0.04 respectively), and HOMA-IR (r=0.18, 
p=0.04). There were also a significant correlation 
between SBP and DBP measured in CBP and UA 
levels (r=0.35, p<0.001, R=0.23, p=0.01 respectively). 
Moreover, patients with AH diagnosed on the basis of 
CBP presented with higher levels of UA (median 384 
[323;432] vs.335 [300;397] μmol/L, p=0.02). This find-
ing was confirmed in girls with AH (386 [324;428] vs. 
324 [289;361] μmol/L, p=0.01), but not in boys (376 
[327;436] vs. 354 [308;426] μmol/L, p=0.39). The odds 
ratio (OR) for boys was 1.42 (0.61; 3.31), p=0.41 for AH 
associated with each 100 unit increase of uric acid. After 
adjusting for age and BMI SDS the odds ratio (OR) was 
1.13 (0.40; 3.23) with a p=0.82. OR for girls was 2.88 
(1.31; 6.30), p=0.01 for AH associated with each 100 
Tab. 1. Comparison of the ABPM results in both  investigated 
groups: with and without AH in CBP.
Parameter
Arterial 
Hypertension 
Without Arterial 
Hypertension
p-value
N 47 83
Age (years) 14.1 (2.85) 
14.5 [12.5;16.2] 
12.8 (2.60) 
13.0 [11.6;14.6]  
0.002
BMI SDS 5.29 (2.39) 
5.20 [3.33;6.22] 
4.16 (1.43) 
3.87 [3.16;5.01]  
0.005
24hSBP SDS 1.10 (1.21) 
1.07 [0.38;1.66] 
0.48 (1.24) 
0.51 [–0.35;1.26] 
0.009
24hDBP SDS 0.07 (1.17) 
0.22 [–0.40;0.82] 
–0.22 (0.87)
–0.28 [–0.85;0.31] 
0.024
24hMAP SDS 0.72 (0.99) 
0.62 [0.30;1.15] 
0.26 (0.88) 
0.26 [–0.55;0.82] 
0.005
dSBP SDS 0.88 (1.19) 
0.76 [0.10;1.54] 
0.20 (1.19) 
0.16 [–0.53;0.96] 
0.002
dDBP SDS –0.25 (1.01)
–0.36 [–0.72;0.64]
–0.54 (0.85)
–0.61 [–1.09;–0.02]
0.054
dMAP SDS 0.45 (0.96) 
0.28 [–0.15;1.15] 
–0.10 (0.94)
–0.07 [–0.72;0.57] 
0.002
nSBP SDS 111 (7.53) 
111 [106;116]   
108 (9.17) 
108 [103;113]   
0.057
nDBP SDS 0.48 (0.92) 
0.46 [–0.17;1.22] 
0.46 (0.96) 
0.39 [–0.18;1.07] 
0.734
nMAP SDS 1.00 (0.80) 
1.00 [0.46;1.40] 
0.81 (0.86) 
0.77 [0.15;1.36]  
0.143
Night dip % 11.0 (5.43) 
10.9 [8.07;15.0] 
9.26 (4.93) 
8.87 [6.39;12.6]  
0.052
AASI 0.43 (0.15)
0.43 [0.35;0.50] 
0.43 (0.15)
0.41 [0.31;0.50] 
0.558
sAASI 0.06 (0.15)
0.08 [–0.04;0.17]
0.04 (0.15)
0.08 [–0.05;0.12]
0.403
Notation used mean (SD) and median [Q1;Q3].
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unit increase of uric acid. After adjusting for age and 
BMI SDS the OR=2.63 (0.93; 7.43), p=0.07 (Figure 1). 
There was a correlation between dSBP measured by 
ABPM and UFC (r=0.30, p=0.026). There were also cor-
relations between cortisol rhythm (8.00 a.m./8.00 p.m.) 
cortisol ratio and nDBP and nMAP (r=0.21, p=0.029), 
(r=0.21, p=0.034). There were no significant differences 
in AASI and sAASI values between patients with and 
without HA (Table 1). There was no correlation between 
AASI and BMI SDS (r=0.07, p=0.419), neither between 
sAASI and BMI SDS (r=0.06, p=0.485) . There was no 
correlation between AASI and biochemical parameters 
(Table 2). There was a correlation between sAASI and 
creatinine level (r=0.29, p=0.002) and negative corre-
lation between sAASI and eGFR (r=–0.23, p=0.009). 
There was no significant correlation between sAASI 
and other biochemical parameters (Table 2).
DISCUSSION
The incidence of obesity in the pediatric population 
has recently increased. As a consequence metabolic 
disturbances and AH are diagnosed more often at a 
younger age (Muntner et al. 2004; Maldonado et al. 
2011). Although many studies have been done in this 
field, the details of the association between metabolic 
consequences of obesity and the development of AH 
remain unclear. Another important issue is the assess-
ment and interpretation of BP measurements in obese 
adolescents owing to the fact that it differs from mea-
surements in adults in various aspects (Flynn et al. 
2014). According to the AHA recommendations issued 
in 2008 and updated in 2014, ABPM may be useful in 
the assessment of pediatric AH, however additional 
data evaluating the efficacy of ABPM in measuring 
the effect of interventions and effectiveness of ABPM-
driven BP control in reversing target-organ damage are 
needed. In the adult population it is well proven, that 
ABPM measurements are more valuable in the assess-
ment of end-organ damage than casual blood pressure 
(CBP) measurements (Perloff et al. 1989; White et al. 
1989; Staessen et al. 1999; Cuspidi et al. 2001; National 
High Blood Pressure Education Program Working 
Groupon High Blood Pressure in Children and Ado-
lescents, 2004). It should be also used as a complemen-
tary diagnostic tool in pediatric patients with obesity. 
The present study is a first attempt to compare CBP 
and 24h ABPM results and metabolic complications 
in obese adolescents in order to assess the suitability 
of these methods for the diagnosis of AH in selected 
groups of patients. There was no significant difference 
in the prevalence of AH diagnosed on the basis of the 
two analyzed methods: 36.2% vs. 33.8% in CBP and 
24h ABPM respectively. The incidence of AH diag-
nosed on the basis of CBP was higher (17–20%), than 
by 24h ABPM, which was lower (75%) compared to 
previously published data (Figueroa-Colon et al. 1997; 
Babinska et al. 2012; Mazor-Aronovitch et al. 2014). 
24h ABPM revealed the presence of white-coat hyper-
tension in 46.8% of patients diagnosed with AH on the 
basis of CBP, that percentage is higher in pediatric, but 
not obese patients (29% according to the results pub-
lished by of Jones et al.) and adult patients (Hornsby et 
al. 1991; Sorof & Portman 2000; Babinska et al. 2012). 
Tab. 2. Correlation between AASI and sAASI and selected 
biochemical parameters. 
Selected biochemical 
parameters
AASI sAASI
r p-value r p-value
creatinin 0.02 0.79 0.29* 0.001
eGFR 0.04 0.66 –0.23* 0.009
fasting glucose 0.01 0.88 –0.01 0.93
120’ post-load glucose 0.07 0.41 0.11 0.2
fasting insulin 0.04 0.63 0.1 0.28
120’ post-load insulin 0.01 0.93 –0.001 0.97
HOMA IR 0.05 0.55 0.08 0.35
Total cholesterol 0.02 0.78 0.02 0.82
LDL cholesterol 0.05 0.60 0.03 0.74
HDL cholesterol –0.001 0.96 –0.1 0.25
Triglicerides 0.04 0.68 0.08 0.39
Uric acid 0.08 0.36 0.08 0.36
Urinary free cortisol 0.01 0.96 0.13 0.35
Morning (8 a.m.) 
blood cortisol level 
–0.06 0.49 0.03 0.35
Evening (8 p.m.) 
blood cortisol level
–0.14 0.16 0.15 0.13
*p<0.05
Fig. 1. Association between AH and uric acid, separately for girls 
(dashed line, stars) and boys (solid line, dots).
587Neuroendocrinology Letters Vol. 36 No. 6 2015 • Article available online: http://node.nel.edu
Hypertension in obese adolescents
This data may suggest the strong impact of the emo-
tional factors on blood pressure in obese adolescents. 
What is even more interesting, 25% of the patients 
with normal CBP results presented masked hyperten-
sion, and elevated BP load during sleep time. Accord-
ing to the data in the literature, it might be associated 
with sleep disturbances and/or sympathetic nervous 
system hyperactivity present in obese patients (Eguchi 
et al. 2011; Feber et al. 2014). Another possible cause, 
that was not analyzed in this context yet, is abnormal 
cortisol rhythm and hypercortisolemia. It has been 
proven that any abnormalities in 24-h cortisol profiles 
may affect BP rhythm (Wojcik et al. 2013). Moreover, 
recently published studies showed that cortisol levels 
were related to obesity and the development of insulin 
resistance in children (Reinehr et al. 2014). The present 
study revealed significant correlations between morn-
ing /evening cortisol ratio and nDBP and nMAP during 
the sleep period (r=0.21, p=0.03), (r=0.21, p=0.03). The 
results of the present study show, that mean 24h-SBP, 
dSBP and dMAP during the activity period were higher 
in AH patients. Nevertheless there were no significant 
differences between patients with and without AH con-
cerning dDBP during the activity period, BP param-
eters during the sleep period or night dip percentage. 
Therefore the usefulness of CBP and 24h ABPM in the 
diagnosis of AH in obese adolescents is comparable, 
however 24h ABPM additionally may indicate white 
coat AH and masked AH. CBP measurements cor-
respond with 24-hSBP and dMAP during the activity 
period, but is not a good enough marker to diagnose 
BP profile abnormalities during the sleep period and 
nDBP. Urinary free cortisol, that reflects cortisol secre-
tion was correlated with dSBP. Interestingly there were 
no significant differences in AASI and sAASI between 
patients with and without HA. Altered AASI is a rec-
ognized risk factor of cardiovascular disorders in adult 
people (Dolan et al. 2006). Its clinical significance in 
children remains unclear. The present study revealed 
significant correlations between SBP measured by 
CBP and metabolic abnormalities secondary to obesity 
(elevation of creatinine and uric acid levels as well as 
insulin resistance parameters). Of particular interest is 
the increase of UA levels in patients with AH. Among 
adults, the association between uric acid levels and 
BP has been known for decades, however the inde-
pendent role of serum uric acid as a marker of cardio-
renal risk is debated (Mellen et al. 2006; Perlstein et al. 
2006; Krishnan et al. 2007; Jones et al. 2008; Viazzi et 
al. 2014). Among participants in the Bogalusa Heart 
Study, UA levels measured during childhood were sig-
nificantly associated with childhood and adult SBP as 
well as DBP (Alper et al. 2005). Moreover, multivari-
ate logistic regression analysis revealed that UA levels 
were associated with a positive history of cardiovascu-
lar events and a high Framingham risk score even after 
adjusting for metabolic syndrome and its components 
(OR=1.10, 95% CI 1.03–1.18; p=0.01; OR-1.28, 95% CI 
1.15–1.42; p<0.001) (Viazzi et al. 2014). The study by 
Bombelli et al. (2014) revealed, that an increase in uric 
acid levels independently predicted new-onset out-of-
office hypertension, and long-term cardiovascular 
and all-cause mortality [30]. In the present study the 
increase of UA levels was significantly associated with 
AH in girls (OR=2.88, p=0.01). Contrary to previously 
published results, UA levels did not correlate with 24h 
ABPM parameters (Jones et al. 2008). 
We can conclude, that while the usefulness of CBP 
and 24h ABPM in the diagnosis of AH in obese ado-
lescents is comparable, 24h ABPM may indicate white 
coat AH. The increase of the CBP parameters is associ-
ated with insulin resistance and hyperuricemia, while 
the increase of 24h ABPM results is proportional to the 
cortisol secretion in obese adolescents. 
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